Scientists are studying a potential new approach to curing epilepsy and depression at the same time, to be treated with drugs called DNMT inhibitors (e.g., decitabine and azacytidine) that are molecular erasers of unnecessary chemical marks on DNA [232]. Here, DNMT1 is linked to depressive disorder.